Skip Navigation.

Sponsored Projects Administration

FDA guidance on drug development tools intended to provide quicker regulatory approvals

Published January 16, 2014 by OSP

Under its new policy, any MDDTs (Medical Device Development Tools) cleared for use will be qualified per the tool's "context of use", not for a specific company, in an effort to reduce the need for redundant reviews by the Center for Devices & Radiological Health.

Read More>